Table 3 Most commonly implicated drugs in Emergency Department (ED) visits for adverse drug events (ADEs)
| Â | ADE-related ED visitsa,b | Serious ADE-related ED visitsa,b | Preventable ADE-related ED visitsa,b | |
|---|---|---|---|---|
ATC 5th level | Drug | No. of Cases (%) | No. of Cases (%) | No. of Cases (%) |
J01CR02 | Amoxicillin/clavulanic acid | 82 (14.3) | 13 (7.6) | 1 (1.4) |
M01AE03 | Ketoprofen | 62 (10.9) | 7 (4.1) | 2 (2.8) |
J01DD04 | Ceftriaxone | 38 (6.6) | 8 (4.7) | 1 (1.4) |
J01CA04 | Amoxicillin | 28 (4.9) | 4 (2.4) | 1 (1.4) |
B01AC06 | Acetylsalicylic acid | 27 (4.7) | 9 (5.3) | 4 (5.6) |
J01MA12 | Levofloxacin | 17 (3.0) | 5 (2.9) | 1 (1.4) |
M01AB05 | Diclofenac | 16 (2.9) | 1 (0.6) | – |
M01AX17 | Nimesulide | 13 (2.3) | 2 (1.2) | 1 (1.4) |
M01AE01 | Ibuprofen | 15 (2.6) | 2 (1.2) | – |
N05BA06 | Lorazepam | 10 (1.7) | 7 (4.1) | 9 (12.7) |
M01AH05 | Etoricoxib | 10 (1.7) | 3 (1.8) | 2 (2.8) |
A10BA02 | Metformin | 9 (1.6) | 6 (3.5) | 3 (4.2) |
H02AB01 | Betamethasone | 9 (1.6) | 1 (0.6) | 1 (1.4) |
B01AA03 | Warfarin | 8 (1.4) | 5 (2.9) | 4 (5.6) |
J01MA02 | Ciprofloxacin | 8 (1.4) | – | – |
C03CA01 | Furosemide | 7 (1.2) | 6 (3.5) | 2 (2.8) |
C09AA05 | Ramipril | 7 (1.2) | 6 (3.5) | – |
N02BE01 | Paracetamol | 6 (1.0) | – | 2 (2.8) |
N02BE51 | Paracetamol, combinations excl. Psycholeptics | 6 (1.0) | – | – |
N03AF01 | Carbamazepine | 6 (1.0) | 4 (2.4) | 2 (2.8) |
B01AA07 | Acenocoumarol | 6 (1.0) | 4 (2.4) | 2 (2.8) |
M03BX05 | Thiocolchicoside | 6 (1.0) | 1 (0.6) | – |
C01AA05 | Digoxin | 6 (1.0) | 6 (3.5) | 2 (2.8) |
N02BA51 | Acetylsalicylic acid, combinations excl. psycholeptics | 6 (1.0) | – | – |